Specialist Registrar in Rheumatology | MRC Clinical Research Fellow | Lupus, APS & therapeutics 🦋🩺 @OfficialUoM @UoMMskResearch 👩⚕️| Own views | she/her
Joined December 2022
- Tweets103
- Following357
- Followers307
- Likes472
Excellent presentation from @sshoopworrall on involving patients to interpret findings from complex statistical modelling at #UKRIME
Mia Rodziewicz retweeted
Now it's the turn of #rheumatology #HealthcareProfessionals in the #UK to share your views and current practice on #ClinicLetter writing
This @RheumatologyUK funded survey is open to all #doctors #nurses #AHPs #pharmacists
👀bit.ly/W2Phcpsurvey
Please share!
Rheumatology MDT members: Do you conduct #Rheumatology outpatient consultations in the UK NHS/HSC? If so, we want to know what you think about writing clinic letters directly to patients. To complete our survey, or for more information, please visit: bit.ly/W2Phcpsurvey
ALT Advert for the 'Writing to patients from rheumatology' healthcare professional survey. Includes the weblink and the team's contact details. Rebecca Goulding, Research Associate: [email protected] and Charlotte Sharp, Consultant Rheumatologist: [email protected]
🫁 Looking forward to answering some clinical questions current guidelines don't cover
🔵 Lots of work ahead!
📝Just published: guideline scope for the new BSR guideline for systemic autoimmune rheumatic disease-related interstitial lung disease.
Learn why our members proposed this guideline and access the scope here: bit.ly/45r6DBV
@ILDIPFDoc_NI @jrironside @MiaRodziewicz
Important work from @sarahdyball1
❕Around half of SLE patients demonstrating a clinical improvement failed actually FEEL better psychologically
Chairing and presenting a talk at #EULAR2024!
Great work by @sarahdyball1 highlighting discordance between clinical and pt reported outcomes from BILAG-BR!
@UoMMskResearch @EMEUNET @Lupusdoc
Great presentation from @RheumJArn on novel reclassification of ANA+ RMD patients
❔could this be used to explain heterogeneity in clinical response to treatment in future trials❔
Mia Rodziewicz retweeted
Efficacy of rituximab in neuropsychiatric #SLE : data from the BILAG biological register.
#EULAR2024
MS
Day 1 at #EULAR2025
🚨 Catch me presenting on real-world outcomes of NPSLE treated with rituximab 16.50-17.00hrs in C8
🔵Also looking forward to hearing CAR-T and novel agent trial updates
Mia Rodziewicz retweeted
✅ TODAY is the official start of #EULAR2024 ✨ with the convergence of 12k+ #Rheumatology specialists & researchers from ALL over the world. The full program of this @eular_org event is truly AMAZING, and for #Lupus there will be 33 oral presentations and almost 200 posters 👍
Mia Rodziewicz retweeted
💥Significant proportion of CTD patients are excluded from Ph3 clinical trials
💥Classification criteria may take several years to be adopted into trial protocols
💥Stringent trial eligibility may lead to poor generalisability for real-world patients
👇
sciencedirect.com/science/ar…
Evidence that unconscious bias affects the care we give
🇺🇸 Don't think this is limited to the USA
🗣️ So important to reflect on our own personal biases but also the social structures we operate within
Military physicians give patients whose military rank is higher better treatment than those who rank lower, according to a new Science study involving 1.5 million patient encounters.
Learn more ⬇️
📄: scim.ag/71M
#SciencePerspective: scim.ag/71N
Mia Rodziewicz retweeted
#bsr24 really important session on inclusivity. Highlighting the challenges around risk correction for ethnicity (also relevant for bone diseases) and explaining why GCA in poc is underreported. Thanks Puja Mehta @RheumatologyUK @AWIRGROUP
🤰"Will I have a healthy baby?"
An excellent summary of the evidence on neurodevelopmental outcomes of individuals born to mothers with rheumatic diseases from @lauraandreoli80
Patient education and empowerment is 🗝️
#BSR24
Great talk on #JIA in adulthood from @KearsleyFleet
2/3 of patients are followed up in adult services and associated with
🟢 Older age of diagnosis
♀️ Gender
👁️ Uveitis
⬇️ Levels of social deprivation
❓ Losing those from deprived groups to follow up
Excellent presentation by @cristianasieiro 👏
465 pregnancies from a single centre in 🇪🇸 across CTDs
🔴More adverse pregnancy outcomes (APOs) in SLE
🟠 Maternal mortality higher in SSc
🟡 aPL independent predictors of APOs
🟢HCQ protective across diseases
🚨 Looking forward to hearing about health inequalities in #sle and #NIEAA cohort
📍 Room 4
#BSR24
#ethnicitysig
@sarahdyball1 @Lupusdoc
A very well deserved award for @rudi_shukla 👏👏 👏
#BSR24
@rudi_shukla receiving the Young Investigator Award at the BSR Congress 2024 🎉
@RheumatologyUK @Kellgrencentre @ManchesterBRC
Great session this morning on the massively overlooked topic of menopause in rheumatic disease
Key points on Menopause, HRT & Rheumatic disease; listen to patients, advocate for patients, educate yourself and patients about the menopause and support research! #BSR24 Excellent presentation 👏
